www射-国产免费一级-欧美福利-亚洲成人福利-成人一区在线观看-亚州成人

USEUROPEAFRICAASIA 中文雙語Fran?ais
China
Home / China / View

Vaccine regulations must be strictly enforced

By Bernhard Schwartlandev | China Daily | Updated: 2016-03-29 08:13

Vaccines have a special role in public health - they are given to healthy children, to prevent serious diseases like hepatitis B, diphtheria, pertussis (whooping cough), and bacterial meningitis. Since the introduction and widespread use of modern vaccines over the last century, hundreds of millions of lives have been saved all over the world. In many countries, diseases such as measles, rubella, and poliomyelitis have been eliminated completely.

Vaccines have become so central to modern public health it would be easy to take them for granted. But vaccines are complex biologic products, requiring strong regulation and management to ensure that they are manufactured properly, and handled correctly at every step from factory door, to clinic, to child. Without careful handling, vaccines can lose some of their potency and effectiveness.

Last week's exposure of a criminal ring re-selling vaccines across China has revealed problems in one part of this supply chain - the distribution of vaccines available for purchase on the private market.

The production of vaccines in China is not at issue here. The World Health Organization is confident in the manufacturing of all Chinese vaccines, based on over 15 years of working closely with the national vaccine regulators. WHO conducted in-depth, independent assessments of China's vaccine regulations in 2010 and 2014, finding both times that China's regulatory system meets or exceeds WHO/international standards.

Both the vaccines that are distributed for free to all children through the Government's Expanded Program on Immunisation, and vaccines available for private purchase, are subject to the same stringent regulations on manufacturing. Thus, all vaccines in China start life the same way - through a process that WHO has certified will produce safe, pure, and effective vaccines.

The issue is what happens once the vaccines leave the factory. The government-distributed, free EPI vaccines are distributed through a tightly managed, cold chain system. A WHO-UNICEF evaluation of the EPI management system in 2014 and 2015 concluded that capacity to effectively manage vaccines is very strong. The problem that last week's events have brought to light, is that distribution of vaccines for the private market do not follow the same high standards. And sadly, this weakness in the system has been exploited by an unscrupulous few intent on making some quick cash, without any apparent regard for the implications for children's health.

China's EPI system is one of the best in the world. The results speak for themselves: over 99 percent of Chinese children are now free for life from chronic hepatitis B as a result of hepatitis B vaccination. Poliomyelitis was eliminated 16 years ago. The incidence of measles is 99 percent lower than during the pre-vaccine era. These accomplishments should inspire confidence.

Vaccines available for private purchase are also important for children's health. In fact, there are some vaccines currently only available on the private market in China, which WHO recommends be included in the national immunization program - including for pneumonia/meningitis, pneumococcal, and rotavirus. This would ensure that all children in China would benefit from the use of these vaccines, and have the benefit of bringing them into the more tightly managed government distribution system.

The ongoing investigation by health authorities and the police into the vaccine ring shows how seriously the Chinese government is taking this incident. WHO is in close contact with the health authorities as they conduct their investigation, and has offered our full support. Ultimately, though, this incident has highlighted the need for much stricter enforcement of vaccine management regulations across the board. Specifically, the same high standards used to distribute EPI vaccines should be used in the distribution of privately-purchased vaccines. This would ensure that the activities which sparked the current investigation would never be able to happen again.

One of the problems with the current events is the risk that parents' confidence in immunisation will be diminished, and they will decline routine vaccination of their children. This would be a terrible outcome - because vaccines are the only way to prevent a range of debilitating, deadly childhood diseases. Improving management, monitoring and oversight of privately purchased vaccines in China is crucial to ensure the safety and effectiveness of all vaccines. Urgent action to achieve is needed to restore the public's trust and confidence in vaccines in China, and to keep China's children healthy.

The author is World Health Organization representative in China.

Editor's picks
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 暖暖视频日韩欧美在线观看 | 免费福利在线看黄网站 | 美女网站在线 | 国产夜色 | 国产精品二区页在线播放 | 久久99精品久久久久久三级 | 日本国产免费一区不卡在线 | 婷婷久久久五月综合色 | 亚洲精品不卡久久久久久 | 91热国内精品永久免费观看 | 国产日本在线视频 | 国产成人女人在线视频观看 | 狠狠色狠狠综合久久 | jyzzjyzz国产免费观看 | 国产一区二区三区久久小说 | 国产成人盗摄精品 | 亚洲免费不卡 | 好湿好紧好痛a级是免费视频 | a毛片网站 | 视频一区欧美 | 怡红院免费全部视频在线视频 | 在线视频观看一区 | 日本美女黄网站 | 久草勉费视频 | 久久成人免费播放网站 | 国内自拍网红在线综合 | 草草在线影院 | 国产九九免费视频网站 | 韩国19禁主播裸免费福利 | 日韩一级片播放 | www.久操| 91免费看国产 | 男人的天堂在线精品视频 | 久久久午夜精品理论片 | 亚洲精品中文字幕在线 | 97成人精品视频在线播放 | 日韩亚洲综合精品国产 | 一级一级一片免费 | 老头老太做爰xxx视频 | 日韩一区二区三区在线视频 | 国产亚洲欧美日韩在线看片 |